Mits Healthcare is stepping into the capital markets with an initial public offering aimed at funding its next phase of expansion and strengthening its competitive position in the pharmaceutical space. The IPO is designed to support capacity enhancement, broaden the product portfolio and deepen market reach in domestic and overseas markets. Coming at a time of sustained interest in healthcare investments, the issue underscores the company’s intent to leverage public capital for long-term growth.